Table V.2: The Number of States That Reported Obtaining Information Related to Drug Compounding from FDAís Website, and How These States Rated the Helpfulness of This Information
Information on the Food and Drug Administrationís (FDA) website Number of states that reported obtaining the information (%) How states that reported obtaining the information rated the helpfulness of the information
  Yes No No response Very or moderately helpful Slightly or not at all helpful Don't know No response
List of FDA-registered outsourcing facilities 38 (76) 10 (20) 2 (4) 32 3 0 3
Names of compounding pharmacies that were inspected by FDA 33 (66) 15 (30) 2 (4) 29 3 0 1
FDA Form 483 inspection observation reports to determine violations found during inspections of compounding pharmacies 35 (70) 13 (26) 2 (4) 25 7 1 2
FDA Form 483 inspection observation reports to determine violations found during inspections of FDA-registered outsourcing facilities 33 (66) 15 (30) 2 (4) 23 6 1 3
FDA warning letters issued to compounding pharmacies 35 (70) 13 (26) 2 (4) 27 6 1 1
FDA warning letters issued to FDA-registered outsourcing facilities 32 (64) 16 (32) 2 (4) 26 4 1 1
Information on recalls of compounded drugs 36 (72) 12 (24) 2 (4) 30 3 1 2

Source: GAO survey of state pharmacy regulatory bodies, survey question 29. | GAO-17-363SP
Note: GAO surveyed the state pharmacy regulatory bodies in the 50 states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands, and all but 4 completed the survey.